I check medical products for a living. It's a job that involves a lot more measuring and documentation than most people expect—cutting open boxes, checking thread depths, reviewing batch certificates. After four years of quality reviews at Henry Schein, I'm convinced those checks are worth every minute. Because when a medical product fails, the price of failure is never just the replacement cost.
Earlier this year, a clinic sent us a sample of the generic dental Teflon tape they were considering. The roll looked exactly like the dental Teflon tape Henry Schein carries in its catalog. Same width, same color, even same core size. But when our lab measured the PTFE thickness, the generic roll came in at 0.08 mm, while the Henry Schein specification required 0.1 mm. That might not sound like much. On a threaded water or air connection, it's a big difference: thinner tape doesn't mold into the threads well, so fittings leak. The clinic had already installed two rolls from an earlier order; they ended up missing an afternoon of patient chair time while a service technician replaced the leaking connections.
That story is the perfect introduction to a problem I keep seeing in medical procurement. Budget pressure leads a buyer to focus on unit price, but unit price doesn't tell you what will happen when the product is placed next to your patients.
The surface problem: 'The cheapest option wins'
Every clinic I've worked with feels the same pressure. The budget gets tighter, the number of patients doesn't go down, and someone in the practice says, 'Why pay $20 for dental tape when we can get the same thing for $9?' It is a fair, understandable question.
My answer usually starts with another question: who verifies that the $9 product has the same density, thickness, and lot consistency as the one you are currently using? If you expect your distributor to do that, it is fair—but then you are relying on a distributor's quality system, not just the price tag.
What is hiding behind the price?
I look at product quality from the inside, and I've noticed three patterns in products that arrive at low price points. They are not universal, but they are common enough to influence how we test before approving a product.
1. Consumables: slight deviations can cause outsized problems
Think about all the types of syringes available today: luer lock, slip tip, low dead-space, insulin-specific, safety syringes. Each type exists to solve a specific clinical problem. Luer lock syringes stay secured to needles; low dead-space syringes reduce medication waste; safety syringes reduce needlesticks. But a cheap syringe can still claim to meet those use cases while being far less predictable in real performance. It may have a slightly looser hub, weaker plastic, or inaccurate graduations. You can't see these problems by looking through the packaging.
We test syringes from every new supplier for hub pull force, plunger friction, dimensional accuracy, and pressure resistance. In 2022, we rejected a low-cost syringe lot because the luer hubs snapped under far less force than the manufacturer specified. If that happens in a multi-dose injection, you don't just swap the syringe—you disrupt the entire procedure.
Diagnostics follow the same rule. The One Step Henry Schein hCG test we stock for clinics comes with batch-specific documentation and manufacturer performance data. It is a biological assay; the antibodies inside have a defined shelf life and temperature tolerance. An unbranded equivalent may not come with that data. I once saw a clinic test a cheap pregnancy test lot: the negative control produced a faint positive line. They ended up doing serum hCG tests on eleven patients to sort out the risk. The money they saved on the strips was less than one serum lab test.
2. Equipment: validation separates equipment from hazards
An autoclave machine is the perfect example. At a glance, two autoclaves can have the same chamber size, same cycle presets, and similar LED displays. The difference appears when you put a thermocouple in the chamber and measure the actual temperature distribution.
A well-built autoclave machine maintains 121–123°C across the chamber throughout the entire sterilization phase, in line with the recommendation in AAMI ST79 for gravity-displacement sterilizers. A budget unit might hit 121°C near the temperature probe but stay at 115°C in a far corner. On paper, the machine says 'sterilization complete.' In reality, the instruments in that corner may not be sterile.
When a clinic brings a bargain autoclave to us for validation, we run the test and show them the temperature map. If it fails, they are left with a decision: risk it, spend thousands of dollars on repeat testing, or pay a restocking fee and start over. The savings on the initial purchase evaporate quickly.
3. Big systems: the sticker price is the smallest part
I've seen the same logic create trouble with large diagnostic equipment. For example, a CT scan machine quote can look remarkable—until you realize installation, training, calibration, and first-year service are not included. In one comparison, a low bid on a CT scanner was 22% below the next quote. But after adding the required site preparation, an extended warranty, and after-hours service, the low bid was 8% higher over two years than a properly supported package.
The issue isn't the machine's sticker price. It is whether anyone is responsible for making the machine work in your building, with your staff, and under your safety protocols. If that responsibility lands on you, you haven't bought a bargain; you've bought a project.
What inaction costs you
Let me bring this down to a number. When we reviewed 22 rejected product lots from 2023 where the price was the main purchase driver, the average hidden cost was roughly $1,860 per lot. That included staff time spent troubleshooting, shipping charges, return paperwork, additional testing supplies, and the clinical time lost while waiting for a replacement. It didn't include the potential cost of patient harm, which can be orders of magnitude higher.
I don't say this to frighten anyone. I say it because I've watched clinics and hospitals make the same calculation under real budget pressure. They choose the cheaper product, then pay for it in slower workflows, rework, and sometimes compromised patient safety.
A better mindset: total value beats unit price
After years of reviewing product lots, I've stopped looking at unit price as an accurate measure of value. The number that matters is total cost, which includes purchase price, installation, verification, consumables, service, downtime, and the consequences of failure.
If the only risk from a product failure is a minor inconvenience, then a lower price makes sense. But for a CT scan machine, an autoclave, a syringe, or a diagnostic test, the failure landscape is different. We all need to act on that difference.
When I review a product, I ask one simple question: if this item fails, what does it actually cost? If the answer is 'a few minutes,' we can choose the cheaper option. If the answer is 'a patient workup, a delayed procedure, or a wrong diagnosis,' the price difference becomes a risk premium, not a saving.
The most expensive medical product you can buy is the one that fails when it matters most.
That is why Henry Schein's quality process exists. It's not a marketing line from the home office. It's the reason we measure tape thickness and test syringe hubs before we put our name on a product. In the end, price is a number on a quote. Quality is what happens after you open the box.